MENU

Stories

Three USC researchers win $4.3 million in awards from California’s stem cell agency

Three scientists from Keck Medicine of USC have won grants exceeding $4.3 million from the California Institute for Regenerative Medicine (CIRM) for research that includes creating a temporary liver for patients, finding novel ways to treat immune disorders and blood diseases, and developing new animal models for heart failure, diabetes and neurodegenerative diseases. The grants, …

Osteoblasts

Broad Clinical Fellows take a stem cell-based approach to liver disease and bone loss

This year’s Broad Clinical Research Fellows are developing stem cell-based approaches for patients of all ages—from two-week-old infants with liver disease, to senior citizens with bone loss following joint replacement surgeries. Since 2015, the Broad Clinical Research Fellowships have enabled physician-scientists at USC, UCLA and the University of California, San Francisco, to engage in one …

Frank Petrigliano, MD, and Denis Evseenko, MD, PhD, have been collaborating on medical innovations to help heal and even regenerate damaged joints. (Photo/Ricardo Carrasco III)

Sports medicine innovations are helping weekend warriors stay in the game

Call them recreational athletes. Couch-to-5K joggers. Weekend warriors. Whichever name you use, they’re the ones who wait all week to hit the soccer field, basketball court or running trail on Saturday morning. They’re up at 5 a.m. for a long run before work or playing softball until the lights switch off at night. They might not …

Frank Petrigliano

Frank Petrigliano named chief of USC Epstein Family Center for Sports Medicine

The USC Epstein Family Center for Sports Medicine at Keck Medicine of USC, which specializes in treating sports-related and recreational injuries affecting the shoulder, knee, hip and elbow, recently announced the appointment of Frank Petrigliano, MD, as the chief of the center and head team physician for the Los Angeles Kings hockey team. He also …

USC researchers converge at the Interdisciplinary Stem Cell Symposium

“The field of stem cell biology is one of our great convergence opportunities,” said USC Provost Michael Quick, addressing an audience of biologists, chemists, physicists, engineers, clinicians and many others. This diverse group came together for the Interdisciplinary Stem Cell Symposium, hosted by USC Stem Cell and the USC Medicine, Engineering, Science and Humanities (MESH) …

Epstein family gift enhances sports medicine research and care at USC

Researchers and clinicians at the Keck School of Medicine of USC’s Department of Orthopaedic Surgery will advance their pioneering work on treatments and techniques to prevent and heal sports-related injuries thanks to a new $10 million gift.

Growing hope: New organs? Not yet, but stem cell research is getting closer

If you lose a limb, it’s lost for life. If you damage a kidney, you won’t grow a new one. And if you have a heart attack, the scars are there to stay. But regenerative medicine is poised to change all of this. Building new tissue is within sight, and USC scientists are among the …

Broad Clinical Research Fellows use stem cells to build bone and combat cancer

This year’s Broad Clinical Research Fellows will apply stem cell-based approaches to two prevalent problems: non-healing bone injuries, which affect 5 million Americans each year; and neuroblastoma, which is the most common solid tumor in children.

Jay R. Lieberman receives $2.2 million NIH grant to fund research on healing difficult bone injuries

Jay R. Lieberman, chair and professor of orthopedic surgery at the Keck School of Medicine of the University of Southern California has received a five-year, $2.2 million grant from the National Institutes of Health’s National Institute of Arthritis and Musculoskeletal and Skin Diseases to research gene therapy to enhance repair of extensive bone injuries. Examples …

Bone defects inspire perfect union between surgeon-scientist and stem cell researchers at USC

As chair of the Department of Orthopaedic Surgery at the Keck School of Medicine of USC, Jay R. Lieberman regularly sees patients with bone defects too severe to heal. This unmet clinical need inspired him to team up with two stem cell biologists, Gage Crump and Francesca Mariani, to find new solutions.

Denis Evseenko receives $2.5 million from California Institute for Regenerative Medicine (CIRM) for osteoarthritis research

The Keck School of Medicine of the University of Southern California (USC) is one of four institutions to receive a multi-million dollar grant from the California Institute for Regenerative Medicine (CIRM) for translational research projects. The $2.5 million grant will support potential osteoarthritis therapies that could significantly impact standards of care for the disease. Arthritis …

USC Stem Cell names second cohort of Broad Clinical Research Fellows

The second cohort of Broad Clinical Research Fellows is making strides towards finding stem cell-based therapies for lymphedema in cancer patients, large bone fractures and short bowel syndrome.

Lieberman takes office as 25th president of national association

Jay R. Lieberman, a principal investigator with USC Stem Cell, is the new president of the American Association of Hip and Knee Surgeons (AAHKS). He is professor and chair of the Department of Orthopaedic Surgery and director of the Institute of Orthopaedics at the Keck School of Medicine of USC and an internationally renowned total …

A Retreat from everything but stem cells

It wasn’t the pristine 27-hole course that drew more than 120 stem cell researchers from USC and beyond to the Desert Princess Golf Resort near Palm Springs. It was the sixth annual retreat for the Eli and Edythe Broad Center for Regenerative Medicine and Stem Cell Research at USC, which took place on October 20­ …

USC announces winners of first Regenerative Medicine Initiative awards

Three newly assembled disease teams within USC Stem Cell will take the early steps this year that might lead to future stem-cell based therapies for certain forms of deafness, bone defects and pediatric leukemia. The teams are winners of USC’s Regenerative Medicine Initiative (RMI), a university-wide program kick-started by $1.2 million in funding from Carmen …

Jay R. Lieberman, MD

Stay connected.